News

Patients with diabetic macular edema treated with intravitreal aflibercept have a significantly higher risk of adverse renal events compared with those treated with ranibizumab.
(HealthDay News) — The number of kidney transplants performed annually in the United States has increased steadily, but with decreasing allocation efficiency, according to a study published online in ...
Sustainable development efforts such as lowering out-of-pocket health expenses can reduce future prevalence of AMR by 5.1 percent.
SGLT2 inhibitors may enable continuation of RAAS inhibitors for hypertension treatment, which is linked with better kidney and cardiovascular outcomes.
The prophylactic efficacy of TMP-SMX was significantly higher in subgroups with baseline lymphopenia, azotemia, microscopic polyangiitis, or relapsed AAV.
Geographic disparities seen, with greater percentage of cardiovascular deaths attributable to di-2-ethylhexylphthalate exposure for South Asia, Middle East.
(HealthDay News) — For female patients with multiple sclerosis (MS), transcutaneous posterior tibial nerve stimulation (TPTNS) and repetitive transcranial magnetic stimulation (rTMS) are comparable ...
The ProVIDE study is a prospective, randomized, double-blind, sham controlled study evaluating the safety and effectiveness of the ProVee® Urethral Expander System for the treatment of lower urinary ...
HIPAA-regulated entities are asked to take steps to ensure full compliance with the current HIPAA security requirements, like data backup.
SGLT-2 inhibitor use, compared with DPP-4 inhibitor use, was associated with a lower incidence of epilepsy among patients with type 2 diabetes. The use of sodium-glucose cotransporter 2 (SGLT-2 ...
The new initiative will focus on research using the beta-propiolactone vaccine platform. (HealthDay News) — The U.S. Department of Health and Human Services and the National Institutes of Health ...
SLE flares continue to occur after ESKD in a substantial subset of patients, warranting closer monitoring. Extrarenal lupus flares continue to occur in more than one-third of patients with end ...